Roche Diagnostics
Search Contact Legal Statement
Index Sitemap link to Roche

 


Roche Molecular Diagnostics' microbiology-related PCR-based testing products include an FDA-approved in vitro diagnostic test for the rapid and reliable detection of M. tuberculosis in untreated patients who have AFB (Acid Fast bacilli) positive smear results within hours as opposed to weeks with conventional culture methods. Roche also offers detection kits for two of the most common non-tuberculosis bacteria, M. avium and M. intracellulare (MAC).

In addition, Roche is developing a portfolio of assays for screening and diagnosis of Healthcare Associated Infections. The first assay to be introduced in this field is the LightCycler® SeptiFast Test MGRADE, which provides species identification within 6 hours of pathogens causing blood stream infections*.

Please note: Not all products are available in all countries.

Diagnostic Assays

Kits for Research

Kits are available for the following parameters:

Instruments

* Not available in the United States
** Available only in Japan
*** For Research Use Only. Not for use in diagnostic procedures. Not available in the United States.
**** For General Laboratory Use. For in vitro use only
***** Not available in the United States; Available in Japan

© 2008, Roche Diagnostics See our Legal Statement - Privacy Policy

This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any valid legal process, regulation, registration or usage in the country of your origin.

Roche Molecular Diagnostics operates in the U.S. as the legal entity Roche Molecular Systems, Inc.